Articles tagged "Liver cirrhosis"

2022 American Transplant Congress
National Attitudes Towards Early Liver Transplantation for Alcoholic Liver Disease
J. Mitchell¹, K. Nijhar¹, K. Herrick-Reynolds², H. Sung¹, P. Chen¹, D. L. Segev¹, E. King¹, A. Cameron¹
¹Department Of Surgery, Johns Hopkins University, Baltimore, MD, ²Department Of Surgery, Walter Reed National Military Medical Center, Bethesda, MD
*Purpose: Pre-transplant abstinence requirements, notably the 6-month sobriety guideline, limit access to liver transplant for patients with severe alcoholic hepatitis (SAH). This study examines the…
2022 American Transplant Congress
Sleeve Gastrectomy Reduces Need for Liver Transplantation for NASH Patients
R. A. Choudhury¹, A. Rouhi², G. Hoeltzel³, Y. Bababekov¹, A. Suarez-Pierre⁴, A. Yule¹, N. Vigneshwar⁴, N. Williams⁵, K. Dumon², J. Pomposelli¹, H. B. Moore¹, E. Pomfret¹, T. Nydam¹
¹Transplantation Surgery, University of Colorado Hospital, Aurora, CO, ²General Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, ³General Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, ⁴Cardiothoracic Surgery, University of Colorado Hospital, Aurora, CO, ⁵General Surgery, Hospital of the University of Pennsylvania, Aurora, CO
*Purpose: Non-Alcoholic Steatohepatitis (NASH) is one of the leading indications for liver transplantation (LT) in the United States. As with the current obesity epidemic, the…
2021 American Transplant Congress
Kidney Transplantation Alone in Patients with Compensated Cirrhosis: A Multicenter Study
A. Kassem¹, S. Asrani¹, S. W. Biggins², Y. Darwish¹, M. Nadim³, B. Fischbach¹, T. Fong³
¹Baylor University Medical Center at Dallas, Dallas, TX, ²University of Washington, Seattle, WA, ³USC - Keck, Los Angeles, CA
*Purpose: Patients undergoing kidney transplant (KTA) often have risk factors for liver disease including viral hepatitis and non-alcoholic fatty liver disease (NAFLD). Recent European Association…
2021 American Transplant Congress
Severe Hypoxemia After Liver Transplantation in the Hepatopulmonary Syndrome
J. Doi, M. Fujiki, G. DAmico, K. Sasaki, T. Diago, F. Aucejo, C. Kwon, B. Eghtesad, K. Hashimoto, C. Miller, Q. Cristiano
Cleveland Clinic, Cleveland, OH
*Purpose: Hepato-pulmonary syndrome (HPS) is a complication of liver disease with liver transplantation as the only curative treatment. However these patients can develop severe hypoxemia…
2021 American Transplant Congress
Assessing the Prevalence of Risk Factors for Osteoporosis and Rate of Screening by Dexa Scan in Patients Referred for Liver Transplant Evaluation
A. France¹, J. Kirk², M. Dokus², B. Al-Judaibi², M. Laryea²
¹Department of Internal Medicine, University of Rochester Medical Center, Rochester, NY, ²Division of Gastroenterology and Hepatology, University of Rochester Medical Center, Rochester, NY
*Purpose: Osteoporosis (OP) and fragility fractures are well-known complications of both chronic liver disease (CLD) and transplant, with a significant increase in the prevalence of…
2021 American Transplant Congress
Iatrogenic Sodium Exposure in Hospitalized Patients with Liver Disease
P. Klem¹, R. Mbangu Kot Mbau², B. Crowther¹, V. Lewis¹, S. Lin¹, E. Patrick³, A. Nadrash¹, K. Schoeppler¹, I. Kim¹
¹Pharmacy, University of Colorado Hospital, Aurora, CO, ²Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, ³Transplant Services, University of Colorado Hospital, Aurora, CO
*Purpose: Numerous medications administered in the hospital setting may contain hidden/additional amounts of sodium in the drug itself and via intravenous (IV) diluents or admixtures.…
2021 American Transplant Congress
Incidence of Pancreatic Exocrine Insufficiency in Patients Undergoing Liver Transplantation
J. Klein¹, M. Rangel¹, I. Ifearulundu¹, Y. Gely¹, Z. Spigel², S. Janardhan³, M. Hertl¹, E. Chan¹
¹Surgery, Rush University Medical Center, Chicago, IL, ²Surgery, Allegheny Health Network, Pittsburgh, PA, ³Hepatology, Rush University Medical Center, Chicago, IL
*Purpose: The purpose of this study was to determine the incidence of Pancreatic Exocrine Insufficiency (PEI) in patients undergoing liver transplantation. Furthermore, patient-specific risk factors…
2021 American Transplant Congress
Dysregulation of Immune Cell Glycolysis and Oxidative Phosphorylation Correlates with Development of Pre-liver Transplant Immune Dysfunction and Post-transplant Mortality
G. Panayotova¹, L. Jin¹, A. Lemenze¹, S. Simonishvili¹, Y. Qin¹, L. Minze², G. Dikdan¹, F. Paterno¹, X. C. Li², M. Ghobrial², J. V. Guarrera¹, K. E. Lunsford¹
¹Transplant Surgery, Rutgers NJMS, Newark, NJ, ²Transplant Surgery, Houston Methodist Hospital, Houston, TX
*Purpose: Cirrhosis-related immune dysfunction contributes to early morbidity and mortality following liver transplant (LT). We have previously identified a pre-LT biomarker panel, the immune frailty…
2021 American Transplant Congress
Impact of Sars-cov-2 Infection in Waiting List for Liver Transplantation: A Cohort Study on Clinical Outcomes
A. Sessa, A. Mazzola, B. Granger, D. Wakselman, M. Atif, V. Martinez, M. Mallet Maxime, D. Thabut, O. Scatton, F. Conti
Hopital Pitie Salpetriere, Paris, France
*Purpose: Infections in cirrhotic patients are associated with an increased risk of liver-related complications (LRC) and mortality. Limited data regarding the prevalence of Coronavirus disease…
2021 American Transplant Congress
Combined Liver-Kidney Transplantation in Adults With End-Stage Liver Disease: Risk Factors in Patients with Chronic Kidney Disease Stages 3-5, Not on Maintenance Dialysis
A. Santos, E. Bueno, M. Leghrouz
University of Florida, Gainesville, FL
*Purpose: We aimed to identify the risk factors for combined liver-kidney transplantation (CLKT) vs. liver transplantation alone (LTA) in end stage liver disease (ESLD) patients…